id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340008-2efzyki4	Haddadi, Kaveh	Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential	2020-09-17		.txt	text/plain	3581	209	42	Similar to other respiratory viruses, severe acute respiratory syndrome coronavirus (SARS-COV-2) may enter the brain via the hematogenous or neuronal route; however, only a few reports are available on the neurological complications of COVID-19. Severe acute respiratory syndrome coronavirus (SARS-CoV-2), a novel coronavirus, originated in China in December 2019 and rapidly progressed into an epidemic infection, such that the World Health Organization (WHO) termed this calamitous virus "coronavirus disease 2019 (COVID-19)". Indeed, while the bulk of research conducted and published thus far has focused on the mechanisms whereby SARS-CoV-2 targets the respiratory system, more recent investigations have reported disconcerting evidence of the entrance of this new coronavirus into the CNS via different ways, resulting in significant damage to this system or even death due to its infection. Some investigators in China reported that more than 30% of their 214 patients with COVID-19 presented with neurological signs and symptoms; they, therefore, concluded that SARS-CoV-2 might attack the CNS through blood or retrograde neuronal routes, causing the destruction of the CNS.	./cache/cord-340008-2efzyki4.txt	./txt/cord-340008-2efzyki4.txt